Piroxicam (PX), meloxicam (MX) and tenoxicam (TX) are nonsteroidal antiinflammatory agents that are widely used in the treatment of rheumatoid arthritis, oesteoarthritis and other joint diseases. They belong to a class of compounds called oxicams. [1] [2] [3] The structures of the investigated drugs are illustrated in Fig. 1 .
Introduction
Piroxicam (PX), meloxicam (MX) and tenoxicam (TX) are nonsteroidal antiinflammatory agents that are widely used in the treatment of rheumatoid arthritis, oesteoarthritis and other joint diseases. They belong to a class of compounds called oxicams. [1] [2] [3] The structures of the investigated drugs are illustrated in Fig. 1 .
The literature revealed that these compounds have been determined by means of a few analytical procedures. These include:
spectrophotometry, [4] [5] [6] [7] [8] spectrofluorometry, 9,10 voltammetry, 11 electrochemical, 12 and chromatography. [13] [14] [15] [16] Gowda et al. 17 reported batch spectrophotometric methods for the determination of piroxicam and propranolol hydrochloride. For piroxicam, ceric ammonium sulfate was used as an oxidant, followed by a reaction of excess oxidant with promethazine hydrochloride or methdilazine hydrochloride. In their work, all measurements were made after 5 min for piroxicam and 10 min for propranolol.
Therefore, in order to achieve good reproducibility, careful time control was needed for all samples.
The above-mentioned assay methodologies often suffer from disadvantages of low sensitivity, poor reproducibility and complicated pretreatment or expensive apparatus. As a result, it was considered to be very useful to develop a simple, fast and inexpensive method for the determination of these drugs in pharmaceutical preparations. Flow-injection analysis (FIA) is characterized by its simplicity, speed, the inexpensive equipment needed and the accuracy of its results. Its ability to control the volumes, mixing patterns, and residence times exactly allows the use of even such chemical procedures that are not reliable when performed manually, either because the reactions do not reach equilibrium or because the reaction products are not sufficiently stable over time. 18 In this paper, a simple, rapid and sensitive flow-injection spectrophotometric method for the determination of MX, TX and PX is presented. The method is based on the oxidation of MX, TX and PX by a known excess of N-bromosuccinimide (NBS) in acidic medium followed by a reaction of the excess oxidant with chloranilic acid (CAA) to bleach its purple color. The proposed method has been successfully applied to the determination of these drugs in pharmaceutical preparations.
Experimental

Chemicals and reagental
Analytical-reagent grade chemicals and deionized water were used to prepare all solutions. Pure active ingredients (meloxicam, tenoxicam and piroxicam) and excipients usually used in pharmaceutical formulations were all kindly supplied by the Jordanian Pharmaceutical Manufacturing, Amman, Jordan. Concentrated acetic acid, sodium acetate, sodium hydroxide, and hydrochloric acid were of analytical-reagent grade and purchased from Merck (Darmstadt, Germany). Acetate buffers were prepared by mixing various volumes of 0.2 M acetic acid and 0.2 M sodium acetate solutions to the required pH value (2.5 -6.4).
N-Bromosuccinimide (NBS).
A stock solution of 0.01 M was prepared daily by dissolving 0.445 g of NBS (Merck) in water and diluting to 250 ml with water.
Chloranilic acid (CAA).
A stock solution of 0.01 M was prepared daily by dissolving 0.523 g of CAA (Merck) in water and diluting to 250 ml with water. NaOH. NaOH (0.1 M) was prepared by dissolving 4.0 g of NaOH (Merck) in 1000 ml of water. Standard stock solutions. A stock solution, 500 μg/ml, of the drug under investigation was prepared by dissolving 50 mg in 100 ml of 0.02 M NaOH. Working standard solutions were prepared by suitable dilution of the stock solution with 0.02 M NaOH. Tablets and capsules. The contents of 10 capsules, or finely ground tablets were weighed and mixed. An accurately weighed portion of the tablet powder, or capsule powder equivalent to 50 mg of the drug under investigation was weighed, and dissolved in about 50 ml of 0.02 M NaOH. The solution was filtered (if necessary) and the clear solution was diluted to 100 ml with 0.02 M NaOH in a 100 ml calibrated flask.
Apparatus
The proposed FI setup is depicted in Fig. 2 . It consists of three channels. All of the measurements were performed with a Varain DMS-100 UV-visible spectrophotometer connected to a linear 1200 recorder. Teflon tubing of 0.51 mm i.d. was used in the flow system. The sample solution was injected via a Rheodyne 6-way injection valve. A home-made confluence point was used to ensure rapid mixing of the sample mixture with NBS in the reaction coil. A sample injection volume of 100 μl was used. The absorbance was measured at 530 nm. Calibration graphs were prepared by plotting the absorbances versus drug concentrations.
Procedure
A volume of 100 μl of prepared sample solution was loaded into the sample loop by means of a syringe. Samples were injected into a 1.0 M HCl carrier stream pumped at a rate of 0.70 ml/min. The NBS solution was added to the carrier stream at a rate of 0.70 ml/min in a confluence manner down stream to ensure rapid and adequate mixing. After that, the CAA solution was added to a stream containing the unreacted NBS. After injection, the valve was returned to the load position when the maximum change in absorbance value had been reached. The absorbance was monitored at 530 nm, at which the maximum absorption occurred, and the increase in absorbance was registered using a chart recorder, at 0.5 mV and with a chart speed of 30 cm/h. When the base line was reached, another slug of sample was injected.
Percent recovery
This study was performed by the addition of known amounts of the drug under investigation to synthetic mixtures containing common excipients in various quantities.
The resulting mixtures were assayed and the obtained results were compared with the expected results.
Results and Discussion
NBS has been extensively used as brominating and oxidizing agents for organic compounds. 19 In aqueous solutions, the oxidizing properties of NBS were attributed to hypobromous acid generated by its hydrolysis. In addition, NBS has been used as an oxidizing agent for several spectrophotometric and chemiluminescence reactions. 20, 21 In the present work, it was found that NBS can oxidize tenoxicam, meloxicam and piroxicam in an acidic medium. In addition, it reacts immediately with chloranilic acid (CAA) in an acidic medium to bleach out its purple color. Therefore, after the oxidation of the drug under investigation by NBS, the excess NBS was reacted with the CAA. The absorption spectrum of the CAA has maximum absorption at 530 nm. Therefore, the different parameters affecting the oxidation reaction, and hence the subsequent determination of these drugs were optimized. These include the acidity of the medium, the concentrations of reagents, the flow rate, the sample volume and the reaction coil length.
Influence of chemical variables
The influence of the NBS concentration on the absorbance was studied at different concentrations of CAA. Fixed volumes (100 μl) of tenoxicam were used and injected into the HCl stream. The effect of changing the concentration of NBS (0.5, 1.0 and 2.0 mM) on the absorbance at variable concentrations of CAA (0.2 -5.0 mM) is shown in Fig. 3 . The figure shows that, for all combinations of NBS and CAA, the maximum analytical signals were achieved when the CAA-to-NBS mole ratio was one. In addition, the analytical signal was higher when both NBS and CAA were at 1 × 10 -3 M, and was thus chosen for further use.
The effect of the pH on the completeness of the reaction, and consequently on the analytical signal, was studied over the pH range 2.2 -11.2. Different buffer solutions (acetate, citrate, borate and phosphate) were tested. No significant influence for the buffer type on the analytical signal was observed. However, all results indicated that the reaction was better carried out in an acidic medium. Therefore, the reactions were carried out using different concentrations of HCl as a carrier solution. A gradual increase in the analytical signal was observed with increasing the HCl concentration (Fig. 4A) . The maximum analytical signal was achieved when the carrier solution was 1.0 M HCl, which was used in all subsequent experiments.
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Influence of FIA variables
The effect of the reaction coil length on the analytical signal was investigated. Two coils were used in the manifold, as shown in Fig. 2 . The first coil (RC1), in which the oxidation of the drug by NBS took place, was changed over the range 30 -200 cm. A considerable increase in the analytical signal was observed upon increasing the coil length up to 90 cm, and started to decrease after that (Fig. 4B) . This indicates that the reaction between the drug under investigation and NBS was fast, and a further increase in the reaction coil length resulted in significant peak broadening and a longer time to go back to the baseline. Therefore, RC1 was chosen to be 90 cm to ensure high sensitivity and a high measurement rate.
Similarly, a significant change in the analytical signal was observed when RC2 was increased from 30 to 200 cm, as shown in Fig. 4B . A gradual increase in the peak height was observed when the length of RC2 increased from 30 to 70 cm and decreased after that. The maximum change in peak height was observed when the coil length was 70 cm. Therefore, a 70-cm reaction coil was chosen.
Flow-rates of the carrier stream and the reagents streams were studied over the range 0.9 and 8.0 ml/min under the same experimental conditions as mentioned above. The peak heights increased nonlinearly when the flow-rates were increased (Fig.  4C) . The maximum peak heights were obtained at 0.7 ml/min for each channel (i.e., the total flow rate for three channels was 2.1 ml/min). Above 2.1 ml/min, the peak heights again decreased, which may have been due to an insufficient reactions time. A flow-rate of 0.7 ml/min for each channel was chosen as a compromise between the peak shape, the sensitivity and the sampling time. With a flow rate of 0.7 ml/min, the analysis time was less than 35 s and the sample throughput was over 100 sample/h.
The effect of the injection volume on the peak height was investigated by injecting different volumes using different lengths of the sample loop. As expected, an increase in the volume of injected sample solution led to an increase in the peak height, as shown in Fig. 4D . Consequently, the sensitivity of measurement could be improved by increasing the sample volume. However, increasing the sample volume leads to an increase in the peak width and time for the signal to retain to the baseline. Thus, a 100 μl volume was chosen that produced a reasonable sensitivity and sampling rate. In case more sensitivity is needed, a larger volume can be used.
Evaluation of the method
The calibration curves for the determination of the investigated drugs were obtained under the optimum conditions. Plots of the absorbance versus the concentrations were straight lines. The linearity was good in each instance, and Beer's law was obeyed for the investigated drugs. Typical calibration data for drugs tested using the proposed FI method are shown in Table 1 . The linearity of the calibration graphs was excellent, and the precision of the measurements ranged from a relative standard deviation (RSD) of 1 to 4% (n = 6). The limits of detection (LOD) were determined as the concentration of the analyte leading to a signal that was three-times the blank standard deviation. Similarly, the limits of quantification (LOQ) were determined as the concentration of the analyte leading to a signal that was ten-times the blank standard deviation. The measurement rate was more than 100 measurements h -1 . The intra-day (within-day) precision was evaluated by the replicate analysis of two different concentrations of meloxicam within the linearity range at different time intervals. The interday (different days) precision was similarly evaluated on several days up to 5 days. Every day, a new calibration graph was constructed. The results in both cases indicated high precision, as the percent RSD did not exceed 5%.
In order to examine the applicability of the proposed FI method to routine pharmaceutical analysis, the effect of common excipients normally used in pharmaceutical formulations was studied.
Synthetic mixtures containing different concentrations of meloxicam in the presence of more than 100 folds of common additives were prepared. The undissolved material was filtered off before injection. No interferences were observed from the additives normally present in commercially available products, and recoveries in the range of 104 to 96% were obtained.
A further evaluation of the proposed FI method in pharmaceutical analysis was performed by carrying out recovery experiments from commercial formulations ( Table 2) . As shown in Table 2 , the recoveries were excellent (97 -104%) for all of the drugs tested, proving the potential of this method 1613 ANALYTICAL SCIENCES DECEMBER 2006, VOL. 22 in pharmaceutical analysis. The closeness of the results to the label claim supports the accuracy of the method. In addition, all of the results were in good agreement with those found by the HPLC procedure. 3 In conclusion, the proposed FI procedure can be used for the analysis of pharmaceutical preparations containing meloxicam, tenoxicam and piroxicam. The method is very simple, using the minimum number of reagents and reaction sequence. The speed of analysis and the precision make this method also suitable for the quality control of formulations containing these drugs, replacing tedious, expensive, and slow official or chromatographic methods. ANALYTICAL SCIENCES DECEMBER 2006, VOL. 22 Table 1 Data for the calibration graphs (n = 6) using the proposed FIA method a. %RSD for 6 determinations. 
